Salvia’s migraine implant could be breakthrough, says FDA

Salvia’s migraine implant could be breakthrough, says FDA

Source: 
Pharmaforum
snippet: 

An implantable neurostimulation migraine device from Salvia BioElectronics has gained Breakthrough Device Designation from the FDA.

Traditional neurostimulation systems are not designed to be compatible with the anatomy of the head, so Netherlands-based Salvia has developed flexible bioelectronic foils (pictured) that could be inserted below the skin in a minimally invasive procedure.